On July 27, 2022, Bavarian Nordic submitted data to Health Canada characterizing shelf life for alternative storage conditions for IMVAMUNE. The IMVAMUNE Vaccine Product Monograph indicates: “Store frozen at -20°C ± 5°C or -50°C ± 10°C or -80°C ± 10°C. Expiry date depends on storage temperature.” However, the Product Monograph does not provide additional information on shelf life if the vaccine is moved between different storage temperatures.